Third, there may be significant heterogeneity between obese patients in their responsiveness to GSK1521498 or other MOR antagonists.
← all excerpts
Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects.
1
—
—